The Effect of Methods Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever

The Effect of Injector and Pacifier Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever

Fever, one of the most common clinical journeys of childhood, makes up a fraction of emergency room admissions. About us-30. High fever, which is one of the first schools in infancy and childhood, can cause health problems such as not applying or starting the intervention. The most preferred method in the fire; antipyretic drug treatment in the hospital is routine . Antipyretics play a role in control plans and estimations of facts for cars of cars, the importance of word of mouth has some problems. In children, hospital, health care, injectors are grown from the breeder after completion, they can be created by red supplementation from the effects such as rearing without completion . resistance children; aspiration is risky, wrong dose is administered. It is stated in relation to teachers and verbal medicines for health. Hansen et al. Working with 61 babies aged 0-24 months, using a pacifier injector and a normal injector, children and temperature monitors. They are from the nipple injector used by mothers and women. There is a need for a new modification in the existing oral drug applications that will be able to support the adaptation and readiness of the child and to be able to effectively administer the drug. This work; Two different methods used to give antipyretic (medication pacifier and colored injector) were planned to be performed as pain, fever and purpose of life (respiratory rate, planning CTA) for the child.

Study Overview

• Status: Completed
• Conditions: Pain; Fever; Heart Rate; Respiratory Rate
• Intervention / Treatment: Other: using a medicine pacifier to give acetaminophen

• Study Type: Interventional
• Enrollment (Actual): 100
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Fatih
    • İstanbul, Fatih, Turkey, 34320
      • Istanbul Unisversity- Cerrahpasa

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: No older than 2 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Applying to the pediatric emergency department with a complaint of high fever (38ºC).
• Being prescribed an antipyretic (paracetamol) by a physician.
• Those whose parents are literate and agree to participate in the study.
• Patients with triage color classification Yellow and Green.
• Children between 0-24 months will be included in the study.

Exclusion Criteria:

• Having used antipyretics in the last 6 hours.
• Being prescribed an antipyretic other than paracetamol by the physician.
• Having trouble in sucking-swallowing coordination.
• Children with chronic disease and neuromotor developmental delay.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: using a medicine pacifier to give acetaminophen	Other: using a medicine pacifier to give acetaminophen; While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.
Active Comparator: using an enjector to give acetaminophen	Other: using a medicine pacifier to give acetaminophen; While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Vital parameters	Heart rate/minute	before oral medications

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	before oral medications

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
vital parameters	Respiratory rate/minute	before oral medications
vital parameters	fever measurement (degrees centigrade)	before oral medications
Vital parameters	Heart rate/minute	after medications 15 minute
Vital parameters	Heart rate/minute	after medications 30 minute
Vital parameters	Heart rate/minute	after medications 45 minute
Vital parameters	Heart rate/minute	after medications 60 minute
Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 15 minute
Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 30 minute
Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 45 minute
Pain score	Wong-baker pain scale. This scale is rated from 0 to 10. 0 is the pain of the pain, 10 is the pain to the beginning. shows. Pain by facial expression evaluation.	after medications 60 minute
vital parameters	Respiratory rate/minute	after medications 15 minute
vital parameters	Respiratory rate/minute	after medications 30 minute
vital parameters	Respiratory rate/minute	after medications 45 minute
vital parameters	Respiratory rate/minute	after medications 60 minute
vital parameters	fever measurement (degrees centigrade)	after medications 15 minute
vital parameters	fever measurement (degrees centigrade)	after medications 30 minute
vital parameters	fever measurement (degrees centigrade)	after medications 45 minute
vital parameters	fever measurement (degrees centigrade)	after medications 60 minute

Collaborators and Investigators

• Sponsor: Istanbul University - Cerrahpasa (IUC)

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2020
• Primary Completion (Actual): December 30, 2021
• Study Completion (Actual): August 30, 2022

Study Registration Dates

• First Submitted: April 2, 2022
• First Submitted That Met QC Criteria: May 4, 2022
• First Posted (Actual): May 9, 2022

Study Record Updates

• Last Update Posted (Actual): December 22, 2022
• Last Update Submitted That Met QC Criteria: December 20, 2022
• Last Verified: December 1, 2022

More Information

Terms related to this study

• Keywords: children, oral medicine, medicine pacifier, injector, antipyretics
• Additional Relevant MeSH Terms: Body Temperature Changes; Fever; Physiological Effects of Drugs; Peripheral Nervous System Agents; Analgesics; Sensory System Agents; Analgesics, Non-Narcotic; Antipyretics; Acetaminophen
• Other Study ID Numbers: E-59491012-604.01.02-2973

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No